Home > News > Top Stories > Forcura Launches Enhanced Referral Technology Designed to Improve Patient Care Transitions Into Home-based Care

Health Technology, Digital Healthcare

Forcura Launches Enhanced Referral Technology Designed to Improve Patient Care Transitions Into Home-based Care

Forcura, a healthcare workflow management company, announced significant product enhancements to its referral workflow technology, which will enable home-based care providers to improve their patient admission rates and intake processes.

Through enhanced AI and machine learning technology, providers can now prioritize referrals to accept into care patients who best fit the practice’s care team and capabilities. Forcura’s technology makes this possible by automatically identifying more patient demographics and data points – including location, referral source and primary and secondary payers, then allowing intake teams to prioritize that data based on a practice’s business rules.

Forcura is also introducing an improved automated capability that will notify providers of duplicate entries. These alerts will help mitigate wasted effort and potential errors when receiving the same referral from multiple channels or at different times.

Overall, the evolved platform serves as a comprehensive referral hub for home-based care providers, continuing to provide a single place for referral management, while enhancing its existing smart technology to better identify and prioritize the right referrals for the practice.

Forcura’s enhanced technology is launched during a time when the referral rejection rate in home-based care remains a significant problem. In a Spring 2023 study, sector leadership reported the industry rejection rate had not changed or worsened since 2022. Home Health Care News reported it had reached 76% in early 2023.

“One of the most strategic pivots a provider can make is to stop accepting any referral and to start accepting the right referrals,” said Annie Erstling, chief operating officer of Forcura. “Getting smarter and more strategic with referral management is a key step to overcoming care transition challenges. In the end, it benefits everyone, including the patient, the provider and the referring physician or facility.”

To further analyze smarter referral management, Forcura is bringing together executives from Reliant at Home and Kaiser Permanente for an online panel conversation on July 24. Payer, provider and technology experts will break down how to identify the right referrals and how it will drive operational and revenue-based improvements. To register, visit the webpage here.

About Forcura

Forcura, a healthcare workflow management company headquartered in Jacksonville, Florida, facilitates continuity of care and improves business performance for providers via its automated workflow, collaboration and analytics SaaS solutions. The company is deeply committed to empowering better patient care and elevating the role of post-acute in the broader healthcare continuum. The company is a KLAS® reviewed technology vendor, is a certified Great Place to Work™ employer, and has ranked for the sixth consecutive year on the Inc. 5000.

Spotlight

More featured news

Spotlight

Related News

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Digital Healthcare

United Medical Uses Oracle Health EHR to Support Growth and Enhance Patient Care for Health Organizations

PR Newswire | October 23, 2023

United Medical, LLC, a multi-specialty ambulatory network with more than 225 full-service healthcare providers, has expanded its 20-year relationship with Oracle Health by another seven years. United Medical plans to deploy Oracle Health's electronic health record (EHR) at additional outpatient surgery centers and accountable care organizations within its network, providing a more intuitive platform to streamline workflows and processes for health practitioners. This helps bring financial, IT infrastructure, consulting services, and support together into one system to help provide more informed and coordinated care. said Kemal Erkan, CEO and President, United Medical. Our relationship with Oracle Health has allowed us to innovate and scale to new capabilities as demand for outpatient care is continuing to grow. This new strategic alignment will help create an easier path toward future growth opportunities as we ensure our practitioners have the latest and greatest technology to help improve their financial outcomes while remaining focused on top-tier patient care. [Source:PR Newswire] With Oracle Health's EHR integrated across its network, United Medical will use a single domain, central patient portal, and billing system where authorized caregivers and staff can easily and effectively manage the patient's care journey. The system will also enable practitioners to see and act on patient information from nearly any location, which will help enhance documentation, simplify follow-up, and improve patient adherence to health maintenance plans. "Teaming with networks like United Medical can help drive organizational efficiency that makes it easier for clinicians and staff to focus on patient care," said Travis Dalton executive vice president and general manager, Oracle Health. "With intelligent technology, Oracle Health is helping providers reduce costs, decrease burnout, and improve the patient experience."

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.